- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03545594
Traumatic Brain Injury; Needs and Treatment Options in the Chronic Phase
Traumatic Brain Injury; Needs and Treatment Options in the Chronic Phase. A Randomized Controlled Community-based Intervention
Traumatic brain injury (TBI) is a condition affecting the persons' central nervous system with a need for extensive and highly specialized initial health care provision followed by comprehensive rehabilitation efforts. Frequent and life-long medical, cognitive, emotional and behavioral changes are expected. The community-based services are largely responsible for dealing with the chronic challenges affecting people with TBI.
120 patients >16 years at the time of injury and between 18 and 72 years at inclusion, with clinical TBI diagnosis on acute admission and verified injury-related intracranial abnormalities reporting cognitive, emotional and physical problems more than 2 years after the injury will be included and randomized to a patient-centered in-home program intervention and treatment as usual. The intervention consists of an individualized and goal-oriented intervention will be provided in the persons' home environment, in close collaboration with family members and local health care providers when available. Assessments will be conducted at baseline, at the end of the intervention 4 months after inclusion and one year after inclusion. Primary outcome is participation (Part-O) and TBI specific health related quality of life (Qolibri). Secondary outcomes include goal attainment within individualized targeted outcome areas, depression and anxiety, symptom burden, unmet health care needs and acceptability of intervention as assessed by patient, family member and health professional. The project will contribute to increased understanding of knowledge transfer processes, and dissemination of evidence based practice for TBI. Thus, the project has the potential to improve the current health care for patients with TBI and its delivery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Traumatic brain injury (TBI) is a condition affecting the persons' central nervous system with a need for extensive and highly specialized initial health care provision followed by comprehensive rehabilitation efforts. Frequent and life-long medical, cognitive, emotional and behavioral changes are expected. The community-based services are largely responsible for dealing with the chronic challenges affecting people with TBI.
120 patients >16 years at the time of injury and between 18 and 72 years at inclusion, with clinical TBI diagnosis on acute admission and verified injury-related intracranial abnormalities reporting cognitive, emotional and physical problems more than 2 years after the injury will be included and randomized to a patient-centered in-home program intervention and treatment as usual. The intervention consists of individualized and goal-oriented strategies provided in the persons' home environment in close collaboration with family members and local health care providers. The original protocol describes a total of 8 sessions of which 2 will be telephone based. Due to the Corona pandemic hittting Norway in March 2020 the home visits had to be reduced and adapted to the individual situation of the participants. The protocol now includes 8 sessions with up to 6 of them being delivered by video. The intervention will be provided in addition to the usual treatment the participants receive in the municipality. The control group will receive the usual treatment provided in the municipality. Assessments will be conducted at baseline, at the end of the intervention 4-5 months after inclusion and one year after inclusion. Primary outcome is participation (Part-O) and TBI specific health related quality of life (Qolibri). Secondary outcomes include goal attainment within individualized targeted outcome areas, depression and anxiety, symptom burden, unmet health care needs and acceptability of intervention as assessed by patient, family member and health professional. In March 2020 a few additional questions regarding the impact of the Corona pandemic on health and participation has been included. The closedown periods of the Norwegian Society during Covid-19 will be used as covariate and/or predictors in the analysis. The project will contribute to increased understanding of knowledge transfer processes, and dissemination of evidence based practice for TBI. Thus, the project has the potential to improve the current health care for patients with TBI and its delivery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0407
- OUH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients >16 years at injury and 18-72 years at inclusion, with clinical TBI diagnosis on acute admission and CT/MRI verified injury-related intracranial abnormalities.
- Patients reporting TBI-related cognitive, emotional and physical problems and/or reduced physical and mental health and/or difficulties with participation in activities with family, friends and in the community at least 2 years after the injury,
- Able to provide informed consent and collaborate in the goal setting processing.
- Living at home at study inclusion.
Exclusion Criteria:
- Patients are excluded if they have severe preexisting neurological disorder that would confound outcome assessments and severe psychiatric diseases
- Patients unable to provide informed consent or participate in a goal-setting process.
- Participants with insufficient fluency in Norwegian to allow for communication with therapists and outcome assessors will also be excluded.
- Substance abuce or history of violence that could represent a security risk for the professionals delivering the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient-centered in home rehabilitation
Eight contacts of about 2 hours duration each delivered over a 4-month period (Six in home visits and two telephone contacts before the Corona pandemic and adjusted to eight contacts and up to six of them video based when necessary during the Corona pandemic) in three phases:
|
Eight contacts (six in-home visits of 1-2 hours duration each and two telephone contacts before the Corona pandemic and eight sessions with up to six of them video delivered if necessary during the Corona pandemic ) delivered over a 4-month period in three phases
|
|
Active Comparator: Control
Usual follow-up assessment and health care and rehabilitation services provided in the municipality
|
Usual follow-up in the municipality
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participation
Time Frame: 12 months
|
Participation assessment and Recombined Tools- Objective (PART-O) (Social domain)
|
12 months
|
|
General Health
Time Frame: 12 months
|
Quality of Life after Brain Injury (Qolibri overall scale, sum score of 6 items )
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global functioning
Time Frame: 4 and 12 months
|
Glasgow outcome scale extended (GOSE) (score 0-8)
|
4 and 12 months
|
|
Depression
Time Frame: 4 months (patients and family) and 12 months intervention (patients)
|
Patients Health Questionnaire (PHQ-9) (patients and family members)
|
4 months (patients and family) and 12 months intervention (patients)
|
|
Physical and mental health (EQ-5D) and quality-adjusted life years, (QALYs)
Time Frame: 4 and 12 months
|
Physical and mental health (scored according to the EQ-5D algoritm )and QALYs (patients) and overall health (on a scale 0-100,family members)
|
4 and 12 months
|
|
Acceptability and satisfaction with the intervention
Time Frame: 4 and 12 months
|
Acceptability Scale assessed by patients, care providers and family members (sum score)
|
4 and 12 months
|
|
Target outcome areas
Time Frame: 4 and 12 months
|
The patient nominate their three most important problems and the difficulties they have with them on a scale from 0 to 4. Changes in the difficulty score is evaluated.
|
4 and 12 months
|
|
Symptom burden
Time Frame: 4 and 12 months
|
Rivermead post-concussion questionnaire (RPQ)(patients) (scoring algoritm)
|
4 and 12 months
|
|
Patient and family members, evaluating self-awareness and functioning. Patient and family members, evaluating self-awareness and functioning
Time Frame: 4 and 12 months
|
Patient Competency Rating Scale (PCRS) (sum score) rated by patient and family member
|
4 and 12 months
|
|
Caregiver burden (Caregiver burden scale)
Time Frame: 4 and 12 months
|
Caregiver burden-family member
|
4 and 12 months
|
|
Anxiety Disorder Measurement (GAD-7)
Time Frame: 4 and 12 months
|
Generalised Anxiety Disorder Measurement (GAD-7) (sumscore 7 items, 0-21)
|
4 and 12 months
|
|
Participation
Time Frame: 4 months
|
Participation assessment and Recombined Tools- Objective (PART-O) (3 domains and total score
|
4 months
|
|
General Health
Time Frame: 4 months
|
Quality of Life after Brain Injury (Qolibri overall scale, sum score of 6 items )
|
4 months
|
|
Participation
Time Frame: 12 months
|
Participation assessment and Recombined Tools- Objective (PART-O) (domain Round and about and Productivity, Total score
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Cecilie Røe, OUH
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TBIcommunity
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.